1. P-310Efficacy of FOLFIRI as a second-line in extrapulmonary poorly-differentiated neuroendocrine carcinoma. (2nd July 2019) Authors: Fabregat Franco, C; Nieva Muñoz, M; Pérez Martín, F; Ruffinelli, J; Santos Vivas, C; Sánchez, C; Salazar, R; Teule, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Ultra-selection of metastatic colorectal cancer patients using next-generation sequencing to improve clinical efficacy of anti-EGFR therapy. (23rd January 2019) Authors: Vidal, J; Bellosillo, B; Santos Vivas, C; García-Alfonso, P; Carrato, A; Cano, M T; García-Carbonero, R; Élez, E; Losa, F; Massutí, B; Valladares-Ayerbes, M; Viéitez, J M; Manzano, J L; Azuara, D; Gallego, J; Pairet, S; Capellá, G; Salazar, R; Tabernero, J; Aranda, E Journal: Annals of oncology Issue: Volume 30:Number 3(2019) Page Start: 439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗